Cargando…
The relationship between HER2 overexpression and angiogenesis in gastric cancer
In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. Tumor formation is associated with angiogenesis in order to secure an abundant supply of oxygen and glucose to cancer cells. The aim of the study was to assess if HER...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211927/ https://www.ncbi.nlm.nih.gov/pubmed/30334990 http://dx.doi.org/10.1097/MD.0000000000012854 |
_version_ | 1783367435622023168 |
---|---|
author | Ciesielski, Maciej Szajewski, Mariusz Pęksa, Rafał Lewandowska, Marzena Anna Zieliński, Jacek Walczak, Jakub Szefel, Jarosław Kruszewski, Wiesław Janusz |
author_facet | Ciesielski, Maciej Szajewski, Mariusz Pęksa, Rafał Lewandowska, Marzena Anna Zieliński, Jacek Walczak, Jakub Szefel, Jarosław Kruszewski, Wiesław Janusz |
author_sort | Ciesielski, Maciej |
collection | PubMed |
description | In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. Tumor formation is associated with angiogenesis in order to secure an abundant supply of oxygen and glucose to cancer cells. The aim of the study was to assess if HER2 overexpression is related to higher microvessel density (MVD) in the tumor stroma. The archival samples of primary tumor from 144 consecutive patients that underwent gastric resection for cancer between August 1, 2006 and December 31, 2013 in the Department of Oncological Surgery of Medical University of Gdańsk were analyzed. CD34 was used as a marker of MVD in the tumor stroma. Both CD34 and HER2 protein expressions were tested by immunohistochemistry. The assays were unsuccessful to estimate HER2 in 10 cases and CD34 in 14 cases due to technical reasons. The results were obtained for 128 patients. HER2 0 and HER2 1+ were considered negative, while HER2+ and HER2 3+ were recognized as positive. Mean MVD (mean number of vessels in the visual field) was 32.4 (median 29.5). Microvessel density was insignificantly higher in HER2 positive tumors. The slight difference was also seen between IHC 2+ and 3+ groups. The differences did not reach the level of statistical significance. Statistical analysis performed in our study did not reveal the significant relationship between HER2 overexpression on the tumor cells and MVD in the tumor stroma. |
format | Online Article Text |
id | pubmed-6211927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-62119272018-11-27 The relationship between HER2 overexpression and angiogenesis in gastric cancer Ciesielski, Maciej Szajewski, Mariusz Pęksa, Rafał Lewandowska, Marzena Anna Zieliński, Jacek Walczak, Jakub Szefel, Jarosław Kruszewski, Wiesław Janusz Medicine (Baltimore) Research Article In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. Tumor formation is associated with angiogenesis in order to secure an abundant supply of oxygen and glucose to cancer cells. The aim of the study was to assess if HER2 overexpression is related to higher microvessel density (MVD) in the tumor stroma. The archival samples of primary tumor from 144 consecutive patients that underwent gastric resection for cancer between August 1, 2006 and December 31, 2013 in the Department of Oncological Surgery of Medical University of Gdańsk were analyzed. CD34 was used as a marker of MVD in the tumor stroma. Both CD34 and HER2 protein expressions were tested by immunohistochemistry. The assays were unsuccessful to estimate HER2 in 10 cases and CD34 in 14 cases due to technical reasons. The results were obtained for 128 patients. HER2 0 and HER2 1+ were considered negative, while HER2+ and HER2 3+ were recognized as positive. Mean MVD (mean number of vessels in the visual field) was 32.4 (median 29.5). Microvessel density was insignificantly higher in HER2 positive tumors. The slight difference was also seen between IHC 2+ and 3+ groups. The differences did not reach the level of statistical significance. Statistical analysis performed in our study did not reveal the significant relationship between HER2 overexpression on the tumor cells and MVD in the tumor stroma. Wolters Kluwer Health 2018-10-19 /pmc/articles/PMC6211927/ /pubmed/30334990 http://dx.doi.org/10.1097/MD.0000000000012854 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Research Article Ciesielski, Maciej Szajewski, Mariusz Pęksa, Rafał Lewandowska, Marzena Anna Zieliński, Jacek Walczak, Jakub Szefel, Jarosław Kruszewski, Wiesław Janusz The relationship between HER2 overexpression and angiogenesis in gastric cancer |
title | The relationship between HER2 overexpression and angiogenesis in gastric cancer |
title_full | The relationship between HER2 overexpression and angiogenesis in gastric cancer |
title_fullStr | The relationship between HER2 overexpression and angiogenesis in gastric cancer |
title_full_unstemmed | The relationship between HER2 overexpression and angiogenesis in gastric cancer |
title_short | The relationship between HER2 overexpression and angiogenesis in gastric cancer |
title_sort | relationship between her2 overexpression and angiogenesis in gastric cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211927/ https://www.ncbi.nlm.nih.gov/pubmed/30334990 http://dx.doi.org/10.1097/MD.0000000000012854 |
work_keys_str_mv | AT ciesielskimaciej therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT szajewskimariusz therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT peksarafał therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT lewandowskamarzenaanna therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT zielinskijacek therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT walczakjakub therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT szefeljarosław therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT kruszewskiwiesławjanusz therelationshipbetweenher2overexpressionandangiogenesisingastriccancer AT ciesielskimaciej relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT szajewskimariusz relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT peksarafał relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT lewandowskamarzenaanna relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT zielinskijacek relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT walczakjakub relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT szefeljarosław relationshipbetweenher2overexpressionandangiogenesisingastriccancer AT kruszewskiwiesławjanusz relationshipbetweenher2overexpressionandangiogenesisingastriccancer |